Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response.

Brown JA, Titus RG, Nabavi N, Glimcher LH. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis. 1996 Dec; 174(6):1303-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.